Lupin gets FDA approval for generic Xenazine tablets
Lupin announced today that it has received final approval for its Tetrabenazine tablets, 12.5 mg and 25 mg from the United States Food and Drug Administration (FDA) to market a generic version of Valeant Pharmaceuticals North America’s Xenazine tablets, 12.5 mg and 25 mg.